Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca2+ handling in rats with chronic myocardial infarction

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 3, 1999, Pages 1038-1044

  Min, Jiang Yong ^b   Sandmann, Steffen ^b   Meissner, Achim ^a   Unger, Thomas ^b   Simon, Ruediger ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ISOPRENALINE; MIBEFRADIL; PLACEBO; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA ADRENERGIC STIMULATION; CALCIUM CELL LEVEL; CALCIUM CURRENT; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG EFFECT; HEART ATRIUM PRESSURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE CONTRACTILITY; HEART PAPILLARY MUSCLE; HEMODYNAMICS; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

ADRENERGIC BETA-AGONISTS; AEQUORIN; AMLODIPINE; ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CHRONIC DISEASE; HEART; HEART FUNCTION TESTS; HEMODYNAMIC PROCESSES; ISOMETRIC CONTRACTION; ISOPROTERENOL; MALE; MIBEFRADIL; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIUM; PAPILLARY MUSCLES; RATS; RATS, WISTAR; VERAPAMIL;

EID: 0032705853     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Amende I, Bentivegna LA, Zeind AJ, Wenzlaff P, Grossman W and Morgan JP (1992) Intracellular calcium and ventricular function. Effects of nisoldipme on global ischemia in the isovolumic, coronary-perfused heart. J Clin Invest 89:2060-2065.
2. Braunwald E (1982) Calcium channel blockers: Pharmacologic considerations. Am Heart J 104:665-671.
3. Diltiazem Postinfarction Trial Group (1989) The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 319:385-392.
4. Hagiwara N, Irisawa H and Kameyama M (1988) Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J Physiol (Lond) 395:233-253.
5. Held PH, Yusuf S and Furberg CD (1989) Calcium channel blockers in acute myo-cardial infarction and unstable angina: An overview. Br Med J 299:1187-1192.
6. 2+ antagonist Ro 40-5967. J Vasc Res 33:71-77.
7. Katz A (1996) Calcium channel diversity in the cardiovascular system. J Am Coll Cardiol 28:522-529.
8. Klein HH, Schubothe M, Nebendahl K and Kreuzer H (1984) The effect of two different diltiazem treatments on infarct size in ischemic, reperfused porcine hearts. Circulation 68:1000-1005.
9. 2+ transient underlie stunning? Circ Res 66:1268-1276.
10. Lakatta EG (1989) Chaotic behaviour of myocardial cells: possible implications regarding the pathophysiology of heart failure. Perspect Biol Med 32:421-433.
11. Litwin SE and Morgan JP (1992) Captopril enhances intracellular calcium handling and β-adrenergic responsiveness of myocardium from rats with postinfarction failure. Circ Res 71:797-807.
12. Lo HM, Kloner RA and Braunwald E (1985) Effect of intracoronary verapamil on infarct size in the ischemic, reperfused canine heart: Critical importance of the timing of treatment. Am J Cardiol 56:672-677.
13. Lüscher TF, Clozel J-P and Noll G (1997) Pharmacology of the calcium antagonist mibefradil. J Hypertension 15 (Suppl 3):S11-S18.
14. 2+ overloaded cardiac muscle. Eur J Pharmacol 316:333-342.
15. 2+ channels by Ro 40-5967. Circ Res 75:144-148.
16. 2+ handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure. Circulation 81 (Suppl III):III21-III32.
17. Mulder P, Richard V, Compagnon P, Henry J-P, Lallemand F, Clozel J-P, Koen R, Mace B and Thuillez C (1997) Increased survival after long-term treatment with mibefradil, a selective T-channel calcium antagonist, in heart failure. J Am Coll Cardiol 29:416-421.
18. Nayler WG, Fassold E and Yepez CE (1978) Pharmacological protection of mitochondrial function in hypoxic heart muscle: Effect of verapamil, propranolol, and methylprednisolone. Cardiovasc Res 12:152-161.
19. Nayler WG, Ferrari R and Williams A (1980) Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium. Am J Cardiol 46:242-248.
20. Noll G, Wenzel RH, Shaw S and Luscher TF (1988) Calcium antagonists and sympathetic nerve activation: Are there differences between classes? J Hypertens 16:S17-S24.
21. 2+ current is expressed in hypertrophied adult feline left ventricular myocytes. Circ Res 73:777-782.
22. Opie LH, Bühler FR, Fleckenstein A, Hansson L, Harrison DC and Poole-Wilson PA (1987) International society and Federation of Cardiology: Working group on classification of calcium antagonists for cardiovascular disease. Am J Cardiol 60:630-632.
23. Pfeffer JM, Pfeffer MA and Braunwald E (1985) Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 57:84-95.
24. Pfeffer MA and Braunwald E (1990) Ventricular remodeling after myocardial infarction: Experimental observations and clinical implications. Circulation 81:1161-1168.
25. Qin D, Jain P, Boutjedir M and El-Sherif N (1995) Expression of T-type calcium current in remodeled hypertrophied left ventricular from adult rat following myo-cardial infraction (Abstract). Circulation 92 (Suppl I):I587.
26. Sadoshima J and Izumo S (1993) Signal transduction pathways of angiotensin II-induced c-fos gene expression in cardiac myocytes in vitro. Roles of phospholipid-derived second messengers. Circ Res 73:424-438.
27. 2+ dependent signalling. Circ Res 76:1-15.
28. Sandmann S, Spitznagel H, Chung O, Xia Q-G, Illner S, Jänichen G, Rossius B, Daemen M and Unger T (1998) Effects of the calcium channel antagonist mibefradil on hemodynamic and morphological parameters in myocardial infarction-induced cardiac failure in rats. Cardiovasc Res 39:339-350.
29. Schmitt R, Clozel J-P, Iberg N and Buhler F (1995) Mibefradil prevents neointima formation after vascular injury in rats: possible role of the blockade of the T-type voltage-operated calcium channel. Arterioscler Thromb Vase Biol 15:1161-1165.
30. Schmitt R, Kleinbloesem CH, Belz CG, Schroeter V, Feifel U, Pozenel H, Kirch W, Halabi A, Woittiez AJ and Welker HA (1992) Hemodynamic and humoral effects of the novel calcium antagonist Ro 40-5967 in patients with hypertension. Clin Pharmacol Ther 52:314-323.
31. Stauss B, Itoi K, Stauss HM and Unger TH (1990) A novel inexpensive computer system to record and analyse hemodynamic data in conscious animals. Eur J Pharmacol 183:863-864.
32. Stauss HM, Zhu YC, Redlich Th, Adamiak D, Mott A, Kregel K and Unger TH (1994) Angiotensin-converting enzyme inhibition in infarct-induced heart failure in rats: Bradykinin versus angiotensin II. J Cardiovasc Risk 1:255-262.
33. Su J, Renand N, Carayon A, Crozatier B and Hittinger L (1994) Effects of calcium channel blockers, diltiazem and Ro 40-5967, on systemic hemodynamics and plasma nordrenaline levels in conscious dogs with pacing-induced heart failure. Br J Pharmacol 113:395-402.
34. Triggle D (1991) Sites, mechanism of action, and differentiation of calcium channel antagonists. Am J Hypertens 4:S422-S429.
35. Tseng GN and Boyden PA (1991) Different effects of intracellular Ca and protein kinase C on cardiac T and L Ca currents. Am J Physiol 261:H364-H379.
36. Unger TH, Becker H, Dietz R, Ganten D, Lang RE, Rettig R, Schomig A and Schwab NA (1984) Antihypertensive effect of the GABA receptor agonist muscimol in spontaneously hypertensive rats: Role of the sympathoadrenal axis. Circ Res 54:30-37.
37. Weishaar RE and Bing RJ (1980) The beneficial effect of a calcium channel blocker, diltiazem, on the ischemic-reperfused heart. J Mol Cell Cardiol 12:993-1009.
38. Yusuf S (1995) Calcium antagonists in coronary artery disease and hypertension: Time for re-evaluation? Circulation 92:1079-1082